科研之友ScholarMate
免费注册
首页 论文 论文详情
赞 收藏 引用

Alemtuzumab Has Durable Efficacy on MRI Outcomes and Brain Atrophy Over 5 Years with Most Patients Free From Treatment for 4 Years: CARE-MS II Extension Study

作者：King J; Traboulsee A; Compston D A S; Hartung H P; Havrdova E; Selmaj K W; Margolin D H; Thangavelu K; Barkhof F
来源：8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS), 2015-11-19 to 2015-11-21.
收藏 分享 被引 浏览
更新时间：2018-01-22 18:26